{
    "clinical_study": {
        "@rank": "137996", 
        "arm_group": [
            {
                "arm_group_label": "Stroke", 
                "description": "Ten individuals with chronic stroke and limb spasticity will be recruited."
            }, 
            {
                "arm_group_label": "Dystonia", 
                "description": "Ten individuals with dystonic limbs and no spasticity will be recruited."
            }, 
            {
                "arm_group_label": "Cerebral Palsy", 
                "description": "Ten individuals with Cerebral palsy with the potential for a mix of dystonic and spastic abnormal tone in their affected limbs will be recruited."
            }, 
            {
                "arm_group_label": "Neurologically normal", 
                "description": "Thirty individuals without neurological injury that are age matched to the rest of the study population will be recruited."
            }
        ], 
        "brief_summary": {
            "textblock": "It is often difficult to quantify and distinguish aspects of abnormal muscle tone due to\n      neurological injury. This makes it difficult to evaluate therapies that aim to reduce the\n      effects of abnormal muscle tone. This research study will evaluate the feasibility of a\n      clinician worn device to capture and quantify features of spasticity and dystonia."
        }, 
        "brief_title": "MyoSense- Automated Muscle Hypertonicity Classification System", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Stroke", 
            "Dystonia", 
            "Cerebral Palsy"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Cerebral Palsy", 
                "Dystonia", 
                "Dystonic Disorders", 
                "Muscle Hypertonia", 
                "Stroke"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Presentation of dystonia and/or spasticity or, if in control group, no neurological\n             injury nor abnormal muscle tone\n\n          -  Over the age of five.\n\n        Exclusion Criteria:\n\n          -  Intolerable pain with manipulation of the knee, ankle, wrist, or elbow\n\n          -  Limited range of motion in the knee, ankle, wrist or elbow due to orthopedic injury\n             or severe contraction.\n\n          -  Cognitive impairment resulting in inability to provide informed consent or complete\n             the protocol.\n\n          -  Under the age of five."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "5 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Sixty individuals, including individuals with and without abnormal muscle tone will be\n        recruited for this study."
            }
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 20, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02076581", 
            "org_study_id": "NS076052-1", 
            "secondary_id": "1R43NS076052-01A1"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "February 26, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Valley View", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "44125"
                }, 
                "name": "Great Lakes NeuroTechnologies"
            }, 
            "investigator": {
                "last_name": "Joseph Giuffrida, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "4", 
        "official_title": "MyoSense- Automated Muscle Hypertonicity Classification System", 
        "overall_contact": {
            "email": "ebrokaw@glneurotech.com", 
            "last_name": "Elizabeth B Brokaw, PhD", 
            "phone": "2164462453"
        }, 
        "overall_official": {
            "affiliation": "Great Lakes NeuroTechnologies Inc.", 
            "last_name": "Joseph P Giuffrida, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Device measurements of clinician applied force relative to limb manipulation speed will be compared to conventional clinical outcome measures. For example, correlation between the slope of the force to speed profile and clinician evaluated spasticity, Ashworth score, will be calculated.", 
            "measure": "Correlation between clinician and device measured abnormal tone type.", 
            "safety_issue": "No", 
            "time_frame": "For each subject clinician and device data will be collected within a single session. Each session will occur over a maximum of two hours. Analysis of all of the subject data will be completed within 30 days of study completion."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02076581"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Great Lakes NeuroTechnologies Inc.", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "The Cleveland Clinic", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "National Institute of Neurological Disorders and Stroke (NINDS)", 
                    "agency_class": "NIH"
                }
            ], 
            "lead_sponsor": {
                "agency": "Great Lakes NeuroTechnologies Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}